Bliss GVS Pharma Ltd share price logo

Bliss Gvs Share Price

NSE: BLISSGVS

BSE: 506197

Small Cap

Healthcare Sector

₹127.90

-24.08

(-15.84%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Bliss Gvs Stock Performance

as on November 7, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹125
    ₹142
    downward going graph

    2.27%

    Downside

    11.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹108.12
    ₹190.97
    downward going graph

    15.47%

    Downside

    49.31%

    Upside

    downward going graph

Bliss Gvs share price movements today

Previous Close
₹151.98
Open
₹140.00
Volume
51.21L
Upper Circuit
₹182.37
Lower Circuit
₹121.58
Day's Low - High
₹125 - ₹142
52 Week Low - High
₹108.12 - ₹190.97

Bliss Gvs Historical Returns

1 Month Return
-15.87 %
3 Month Return
-27.92 %
1 Year Return
+ 2.93 %
3 Year Return
+ 72.72 %
5 Year Return
-23.41 %

Bliss Gvs Fundamentals

as on November 7, 2025 at 4:01 pm IST

Market Cap

₹1,352.19 Cr

Return on Equity (ROE)

6.74

PE Ratio (TTM)

14.61

Return on capital employed (ROCE)

9.16

Industry PE ratio

42.05

Beta (LTM)

1

P/B Ratio

1.17

Dividend Yield

0.43

PEG Ratio

3.35

Quarterly Earnings Growth YOY

11.29

EPS (TTM)

8.57

Sector

Pharmaceuticals

Book Value

99.68

Technical Analysis

Bearish

View Technical Analysis

Bliss Gvs Stock Valuation

as on November 7, 2025 at 4:01 pm IST

Bliss Gvs in the last 5 years

  • Overview

  • Trends

Lowest (7.08x)

August 22, 2019

Today (14.61x)

November 6, 2025

Industry (42.05x)

November 6, 2025

Highest (576.11x)

January 3, 2022

LowHigh

Today’s Price to Earnings Ratio: 14.61x

Bliss GVS Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bliss Gvs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bliss GVS Pharma Ltd image
Bliss GVS Pharma Ltd
NA1,352.19-4.68%0.5690809
Advanced Enzyme Technologies Ltd image
Advanced Enzyme Technologies Ltd
BUY3,474.21-0.13%0.53133636
Starsource Multitrade Ltd image
Starsource Multitrade Ltd
NA17.40121.46%0.00NANA
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,362.63-1.78%0.7428311
Novartis India Ltd image
Novartis India Ltd
NA2,052.796.4%0.00100390
See all

Bliss Gvs Stock’s Investor Sentiment and Interest

Search interest for Bliss GVS Pharma Ltd Stock has increased by 144% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:144% versus previous 30 day period

Bliss GVS Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
205.72
184.78
159.52
211.88
200.72
198.13
183.64
217.68
210.42
197.99
207.47
244.4
Other Income
5.65
2.98
5.11
12.6
5.42
5.6
4.12
5.04
15.27
12.07
35.45
20.18
Total Income
211.36
187.76
164.63
224.48
206.14
203.73
187.77
222.72
225.68
210.05
242.92
264.58
Expenses
158.03
178.54
135.31
157.51
157.02
198.98
149.31
176.2
180.63
176.9
166.14
212.64
Operating Profit
47.69
6.24
24.21
54.37
43.7
-0.85
34.33
41.48
29.79
21.09
41.33
31.76
Operating Profit Margin %
23.18%
3.38%
15.18%
25.66%
21.77%
-0.43%
18.69%
19.06%
14.16%
10.65%
19.92%
13%
Profit Before Interest, Tax and Depreciation
53.33
9.22
29.33
66.97
49.12
4.75
38.45
46.51
45.05
33.15
76.78
51.94
Interest
1.26
5.08
1.49
1.45
2.12
1.85
1.53
3.83
1.08
1.68
5.47
3.04
Depreciation
4.64
4.88
6.19
6.39
6.95
6.85
6.85
6.98
7.55
8.04
8.2
8.26
Profit Before Tax
47.43
-0.74
21.65
59.13
40.05
-3.95
30.07
35.7
36.42
23.43
63.11
40.64
Tax Paid
17.65
-4.21
7.28
16.08
10.97
0.96
7.96
10.01
10.62
6.79
18.74
12.04
Profit After Tax
29.79
3.46
14.37
43.04
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
Total Net profit including share of profit / Loss from associate company
29.79
3.46
14.37
43.04
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
EPS
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
Actual EPS
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
Adjusted EPS
2.68
0.34
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
Diluted EPS
2.64
0.33
1.41
3.98
2.6
-0.86
1.93
2.29
2.27
1.46
4.04
2.54

Bliss GVS Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
772.29
814.64
898.57
689.31
577.21
747.45
751.59
770.24
809.73
Other Income
12.51
26.54
37.63
39.19
20.22
31.49
17.79
28.74
36.49
Total Income
810.94
841.18
936.2
728.49
597.43
778.95
769.37
798.98
846.22
Expenses
595.7
651.7
740.93
579.37
470.56
702.71
634.27
648.82
683.04
Operating Profit
176.59
162.94
157.64
109.94
106.65
44.74
117.32
121.42
126.69
Operating Profit Margin %
22.87%
20%
17.54%
15.95%
18.48%
5.99%
15.61%
15.76%
15.65%
Profit Before Interest, Tax and Depreciation
215.24
189.48
195.27
149.12
126.87
76.24
135.11
150.16
163.18
Interest
19.69
22.8
4.41
7.57
5.51
4.74
10.36
6.91
8.12
Depreciation
20.14
21.38
8.94
12.59
17.23
17.33
18.67
26.38
29.42
Profit Before Tax
175.41
145.3
181.92
128.96
104.13
54.17
106.08
116.87
125.64
Tax Paid
62.72
56.63
55.25
33.72
30.15
31.04
29.33
35.29
35.39
Profit After Tax
112.68
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
Total Net profit including share of profit / Loss from associate company
112.68
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
EPS
7.95
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Actual EPS
7.95
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Adjusted EPS
7.95
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Diluted EPS
7.95
5.7
11.99
9.43
6.49
1.43
6.72
7.11
7.95

Bliss GVS Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
112.95
289.47
17.64
39.95
46.7
63.97
135.48
34.31
102.82
105.91
Cash Flow from Investing Activities
-51.55
-249.23
47.87
-78.7
-40.09
-45.37
-102.89
-6.36
-83.34
-75.34
Cash Flow from Financing Activities
-40.25
-10.13
-75.98
16.83
-6.3
-20.79
-23.73
-24.95
-20.88
-30.35
Net Cash Flow
22.51
30.11
-10.46
-21.91
0.3
-2.21
8.85
3.02
-1.42
0.23

Bliss Gvs Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
34.46%
35.04%
35.12%
35.06%
34.97%
34.97%
34.9%
34.82%
35.1%
35.29%
35.44%
35.39%
DII
6.63%
6.63%
6.62%
6.61%
6.59%
6.59%
6.58%
6.57%
6.55%
6.55%
6.54%
5.98%
FII
0%
0%
0%
16.31%
0%
14.73%
13.25%
12.13%
13.51%
13.18%
12.65%
13.27%
Public
42.38%
41.73%
41.75%
42.01%
43.08%
43.71%
45.27%
46.49%
44.84%
44.98%
45.36%
45.36%
Total Outstanding Shares
10,41,52,672
10,41,52,672
10,42,23,172
10,43,98,672
10,46,90,822
10,46,90,822
10,48,82,572
10,51,44,472
10,53,66,272
10,53,70,272
10,54,97,522
10,56,49,472
Total Shareholders
44,983
43,041
42,182
43,234
40,758
45,157
44,737
52,937
49,558
49,517
46,707
44,461

Mutual Funds that own Bliss Gvs Stock

Check out the Mutual Funds with significant holdings in Bliss Gvs.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.08%
883

Bliss Gvs Corporate Actions

View detailed summary of the earnings and dividend history of Bliss Gvs.

  • Bliss GVS Pharma Ltd Earnings Results

    Bliss GVS Pharma Ltd’s net profit jumped 12.32% since last year same period to ₹27.25Cr in the Q2 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -36.69% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Bliss GVS Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 per share on 12 May 2025 - translating a dividend yield of 0.39%.

    Read More about Dividends

Indices Featuring Bliss Gvs Stock

Check stock indices that include Bliss Gvs.

BSE Healthcare

₹44,353.90

-0.35 (▲-153.61%)

BSE Small-Cap

₹53,052.16

-0.01 (▲-5.11%)

Insights on Bliss GVS Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 210.05 Cr → 264.58 Cr (in ₹), with an average increase of 10.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 12.65% to 13.27% in Sep 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 45.36% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.3% return, outperforming this stock by 14.2%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.44% to 35.39% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BLISSGVS stock has moved down by -14.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 43.04 Cr → 27.25 Cr (in ₹), with an average decrease of 36.7% per quarter

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company providing products in the antimalarial, antifungal, antibacterial, anti-inflammatory, and antibiotic segments. Boasting one of the largest portfolios of Suppositories and Pessaries dosage forms, the leading company is the only EUGMP certified suppositories manufacturer in India, and has a research and development centre with over 50 scientists certified by the Department of Scientific and Industrial Research.

Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.

To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.

Revenue: ₹244.40Cr as on September 2025 (Q2 FY26)
Net Profit: ₹28.59Cr as on September 2025 (Q2 FY26)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
OrganisationBliss GVS Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSubramanian R Vaidya
E-voting on sharesClick here to vote

FAQs

What is Bliss Gvs share price today?

Bliss Gvs share price today stands at ₹127.9 as on at the close of the market. Bliss Gvs share today touched a day high of ₹142 and a low of ₹125.

What is the 52 week high and 52 week low range for Bliss Gvs share?

Bliss Gvs touched a 52 week high of ₹190.97 and a 52 week low of ₹108.12. Bliss Gvs share price today i.e. is closed at ₹127.9, which is -33.03% down from its 52 week high and 18.29% up from its 52 week low.

What is Bliss Gvs's market capitalisation today?

Bliss Gvs market capitalisation is ₹1,352.19 Cr as on .

How to buy Bliss Gvs shares?

To buy Bliss Gvs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BLISSGVS or Bliss GVS Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bliss Gvs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bliss Gvs trading volume today?

Bliss Gvs trading volume is 51.21L as on . This means that 51.21L shares of Bliss Gvs were bought and sold on the stock market during today's trading session.